Bioanalytical Testing Services Market by Offering [Bioanalytical Testing (Compound Screening and Cell-Biology, Virology Testing, Serology/Immunogenicity and Neutralizing Antibodies, Toxicology Services, Biomarker and Cytokine Testing, Pharmacokinetic Testing, GLP Sample Analysis, and Other services) and Testing Platforms], Application (Oncology, Neurology, Metabolic Disorders, Hematology, Immunology, Orthopedics, and Others), End User (Biotech & Pharmaceuticals Company, CDMO & CMO, Clinical Research Organizations, Healthcare Institutes, and Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026486 | Pages: 100 | Industry: Medical Device | Date: Sep 2022 | Type: Global

The market crossed US$ 3.38 billion mark in 2022 and is expected to hit US$ 6.17 billion by 2030, recording a CAGR of 7.8 % during the forecast period.

Rising demand for analytical testing and usage of the same in biologics and biosimilars

Biologics represent one of the most promising new therapeutic areas and are becoming increasingly important in the pharmaceutical market as around 800 products are in the pipeline that are yet to be commercialized and will address the cure for various chronic diseases. However, considering the high cost of biologics and the rising focus from governments in reducing healthcare costs, the focus on biosimilars has increased in recent years. The impending expiry of the patents and exclusivity periods of biologics have also created opportunities for the development of follow-on biologics or biosimilars. According to GaBi, twelve biologics with global sales of more than US$ 67 billion are scheduled to go off-patent in major markets by 2020, with more biologics likely to follow. The expected rise in biosimilar research and development activities will bring with it a growing demand for the associated bioanalytical testing services—compatibility studies for biosimilars, stability testing, product release testing, and protein analysis of biosimilars that will eventually reduce the risks associated with drug development. Moreover, the introduction of biosimilars and the shift towards continuous processing create the need for more rapid and sensitive analytical techniques.

Within the report, the market is segmented into offering, application, end user, and geography. By offering, the market is further bifurcated into bioanalytical testing and testing platforms. Bioanalytical testing is again segmented into compound screening and cell-biology, virology testing, serology/ immunogenicity and neutralizing antibodies, toxicology services, biomarker and cytokine testing, pharmacokinetic testing, GLP sample analysis, and other services. On the application, the market is segmented into oncology, neurology, metabolic disorders, hematology, immunology, orthopedics, and others. Based on end user, the market is segmented into biotech & pharmaceuticals company, CDMO & CMO, clinical research organizations, healthcare institutes, and others. Geographically, the market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

Get more information on this report :

Outsourcing analytical testing services is expected to provide lucrative opportunities

Pharmaceutical companies have begun outsourcing several research and development activities that are not core to their internal structure. Companies are trying to be more efficient in the drug development process by focusing on their internal core competencies to bring new products into the market that are cost-efficient in nature. Cost reductions, efficiency increases, and optimal staffing are key advantages driving the outsourcing of bioanalytical testing for large companies. In the pharmaceutical sector, the analytical and testing services were the most-outsourced services, followed by solid-dosage form manufacturing, injectable manufacturing, clinical trials, formulation development, and research and development activities. This trend is backed by an increase in the numbers, capabilities, and volumes of contract research organization and the liking for specific providers over the long-term as opposed to short-term contracts. In the following years, outsourcing as a strategy is anticipated to gain greater notoriety. When coupled with the growth in biologic and biosimilar, this factor is projected to create a favorable option. The outsourcing of bioanalytical testing services supports pharmaceutical companies, reduces the risks by avoiding expenditure on purchasing analytical equipment and maintaining workforce, particularly when development efforts are in the initial stages.

Oncology segment in application captured the largest share in 2022

The oncology segment accounted for the largest share in the global bioanalytical testing services market in 2022. The surging number of clinical trials conducted for cancer is driving the segment growth. With the increasing burden of cancer on healthcare systems worldwide, both government and private organizations are increasingly focusing on developing novel cancer therapies. This is expected to drive the demand for bioanalytical testing services for cancer drugs innovations that are in their clinical trial stages. ICON, Syneos Health, and PAREXEL International are some of the leading players offering services for the clinical trials of oncology drugs.

Recent strategic developments in bioanalytical testing services market

The bioanalytical testing services market has undergone several significant developments, and a few of these have been mentioned below:

  • In February 2022, SGS opened a bioanalytical laboratory equipped with leading instrumentation and equipment, including a Watson LIMS system and WinNonlin software.
  • In October 2021, Syneos Health acquired RxDataScience. This acquisition delivers AI and data engineering expertise, enterprise analytics, and technology-enabled solutions to accelerate customer performance.


The bioanalytical testing services market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Charles River Laboratories International, Inc., Eurofins Scientific SE, Labcorp, Envigo, Medpace, Intertek Group plc, Syneos Health, Frontage Labs, Absorption Systems, and PAREXEL International Corporation are among the prominent players operating in the market.

Target audience for the report:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Government bodies, such as regulating authorities
  • Research institutes, organizations, and consulting companies
  • Academic Institutes

Scope of the report:

In this report, the market has been segmented on the basis of:

  • By Offering
    • Bioanalytical Testing
      • Compound Screening and Cell-Biology
      • Virology Testing
      • Serology/Immunogenicity and Neutralizing Antibodies
      • Toxicology Services
      • Biomarker and Cytokine Testing
      • Pharmacokinetic Testing
      • GLP Sample Analysis
      • Other services
    • Testing platforms
  • Application
    • Oncology
    • Neurology
    • Metabolic Disorders
    • Hematology
    • Immunology
    • Orthopedics
    • Others
  • End-user
    • Biotech & Pharmaceuticals Company
    • CDMO & CMO
    • Clinical Research Organizations
    • Healthcare Institutes
    • Others
  • Region
    • North America
      • US
      • Canada
      • Mexico
    • Europe
    • Asia Pacific (APAC)
    • Middle East & Africa
    • South & Central America

Companies profiled:

    • Charles River Laboratories International, Inc.
    • Intertek Group plc
    • Eurofins Scientific SE
    • Labcorp
    • Envigo
    • Medpace
    • Syneos Health
    • Frontage Labs
    • Absorption Systems
    • Affinity Life Sciences, Inc.
    • PAREXEL International Corporation
    • Other Market Participants

Companies profiled:
- Charles River Laboratories International, Inc.
- Intertek Group plc
- Eurofins Scientific SE
- Labcorp
- Envigo
- Medpace
- Syneos Health
- Frontage Labs
- Absorption Systems
- Affinity Life Sciences, Inc.
- PAREXEL International Corporation
- Other Market Participants

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Purchase Options
Single User License
Site License
Enterprise License